Jagsonpal Pharma to acquire 85 percent stake in Aequitas Healthcare for Rs 20.8 Cr

Listed Co AcquisitionStrategic Transactions View source PDF

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.2%1-day move

₹230.11

prior close

₹243.69

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+2.6+6.0+6.7+6.6+3.2+2.1+3.3+3.4+3.9+0.7-3.5———

Up moveDown movePending

AI summary

Jagsonpal Pharmaceuticals will acquire 85 percent stake in Aequitas Healthcare for Rs 20.8 Cr in cash, funded from internal accruals. Aequitas sells pharma products to hospitals with FY26 revenue of Rs 53.31 Cr. The deal gives Jagsonpal entry into the hospital segment and access to institutional doctor networks. Expected to close by July 15, 2026. Not a related party deal.

Likely market impact

Strategic entry into hospital segment, expanding reach beyond retail. Aequitas adds around Rs 53 Cr revenue. Funded through internal accruals.